Evicenter
Ubrelvy (ubrogepant) in Acute treatment of migraine
Manufacturer
AbbVie Inc.
Prescribing information
Ubrelvy (opens in a new tab)
Questions
59
Last updated

All questions

Pharmacology: Ubrelvy (ubrogepant) in acute treatment of migraine

6 questions · 3 sources

Mechanism

How does Ubrelvy work (mechanism of action)?

Note: The first passage is from the Prescribing Information; the others are from the mechanism of action page of the Ubrelvy HCP site.

Is Ubrelvy known to constrict blood vessels?

Note: The statement is on the mechanism of action page of the Ubrelvy HCP site, under a heading comparing UBRELVY with triptans, and cites the American Headache Society position statement on integrating new migraine treatments into clinical practice (Headache 2019). The Prescribing Information makes no statement about vasoconstriction; it lists hypertension and Raynaud's phenomenon, reported after use of CGRP antagonists including UBRELVY, under Warnings and Precautions.

Pharmacokinetics

How is Ubrelvy metabolized and eliminated?

How long does Ubrelvy stay in your system (half-life)?

How fast is Ubrelvy absorbed (time to peak concentration)?

Components

What are the inactive ingredients in Ubrelvy?